Evidence map›Paper›PMID 30858630›Full record

ReviewReumatologia2019

The rheumatoid hand in the light of fluorescence: a diagnostic technique of the future?

Paweł Żuchowski, Marzena Waszczak-Jeka, Szymon Kudlicki, Sławomir Jeka

Open access · diamondAbstract readReview
In one paragraph

Review in Reumatologia, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Paweł ŻuchowskiDepartment of Rheumatology and Connective Tissue Diseases, Dr. Jan Biziel University Hospital No. 2 in Bydgoszcz, Poland.
Marzena Waszczak-JekaClinical Trials Center, Warsaw, Poland.
Szymon KudlickiNon-public Health Care Centre "Nasz Lekarz", Bydgoszcz, Poland.
Sławomir JekaDepartment of Rheumatology and Connective Tissue Diseases, Dr. Jan Biziel University Hospital No. 2 in Bydgoszcz, Poland.
Collegium Medicum in Bydgoszcz · PLUniversity of Bydgoszcz · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fluorescence spectroscopy is usually applied in physics, chemistry and related sciences. However, in recent years we can observe a growing interest in fluorescence spectroscopy for medical diagnostics. Currently, it is beginning to be used in the monitoring of rheumatoid arthritis (RA) activity. As the knowledge on RA increases, growing importance is being placed on the evaluation of synovitis. Today, it is difficult to imagine contemporary rheumatology without ultrasound (US) and magnetic resonance imaging (MRI). However, it turns out that these are not the only methods allowing one to visualise subclinical lesions, particularly synovitis. Fluorescence optical imaging (FOI) is also useful for the evaluation of inflammatory lesions in the joints. In the future, FOI may become competitive with "traditional" imaging studies. It is characterised by low cost, short duration and similar sensitivity to US.

Indexed as

fluorescencemedical diagnosticsrheumatoid arthritisultrasonography

Identifiers

PMID30858630
PMCPMC6409828
OpenAlexW2922213716

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.